Stay updated on Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial

Sign up to get notified when there's something new on the Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study status is updated to terminated due to financial hardships, and results have been posted with dates and linked documents. The prior Active, not recruiting status and earlier submission notes were removed.
    Difference
    2%
    Check dated 2026-02-18T06:58:44.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.2 is now shown. The lapse-in-government-funding notice and the prior Revision: v3.4.1 text were removed.
    Difference
    0.5%
    Check dated 2026-02-11T06:16:04.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding, informing users that information may not be up to date and directing them to cc.nih.gov and opm.gov for updates while noting the NIH Clinical Center is open. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T04:46:20.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI/metadata updates include a glossary toggle, a new 'Last Update Submitted that Met QC Criteria' label, and revision/version information in the footer, plus capitalization tweaks. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:05:24.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No study data or eligibility details were changed.
    Difference
    0.1%
    Check dated 2026-01-14T02:43:11.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a top-level Locations section listing Michigan, Missouri, and Ohio as study sites, replacing the prior separate location entries. The page revision also updates from v3.3.2 to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-23T13:55:41.000Z thumbnail image

Stay in the know with updates to Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial page.